The Bioresearch Monitoring (BIMO) Program, operated by the U.S. Food and Drug Administration (FDA), conducts on-site inspections and data audits in order to effectively monitor the compliance of all FDA-regulated research....more
7/12/2023
/ Audits ,
Biotechnology ,
Clinical Trials ,
FDA Warning Letters ,
Food and Drug Administration (FDA) ,
Inspections ,
Institutional Review Board (IRB) ,
Investigational New Drug Application (IND) ,
Life Sciences ,
Medical Devices ,
Medical Research ,
Pharmaceutical Industry ,
Sponsors
The U.S. Food and Drug Administration’s (FDA’s) Office of Bioresearch Monitoring Operations (OBIMO) oversees domestic and foreign agency field inspections for clinical and non-clinical research. In particular, OBIMO manages...more